BRYNJELSEN SEAN 4
4 · Eton Pharmaceuticals, Inc. · Filed Feb 15, 2024
Insider Transaction Report
Form 4
BRYNJELSEN SEAN
DirectorPresident & CEO10% Owner
Transactions
- Award
Stock Option (Right to buy)
2024-02-13+438,633→ 2,473,014 totalExercise: $4.42Exp: 2034-02-12→ Common Stock (438,633 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 13, 2028.